Company / Goodwill
Abbott Laboratories Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$24.0B
FY2025
5-year range
$22.8B / $24.0B
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#8 of 136
Health Care
What the data says
Among 136 Health Care companies, Abbott Laboratories is in the top 6% for goodwill. Goodwill has fluctuated over the past 10 years, ranging from $7.7B in FY2016 to $24.0B in FY2025.
Based on SEC 10-K filings.
$24.0B in FY2025 with a 5-year CAGR of +0.2%. Top quartile in the Health Care sector.
Remained stable around $24.0B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +1.8%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 136This company $24.0B Sector average $5.2B
▼
+358.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.2%, indicating consistent growth.
- In FY2025, goodwill increased 4.0% year-over-year.
- Ranks #8 out of 136 companies in the Health Care sector.
- Lowest goodwill in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.0B | +4.0% |
| FY2024 | $23.1B | -2.4% |
| FY2023 | $23.7B | +3.9% |
| FY2022 | $22.8B | -1.9% |
| FY2021 | $23.2B | -2.2% |
| FY2020 | $23.7B | +2.4% |
| FY2019 | $23.2B | -0.3% |
| FY2018 | $23.3B | -3.2% |
| FY2017 | $24.0B | +212.6% |
| FY2016 | $7.7B | -20.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026